Current Size: 100%
Survival statistics
Note: Survival is presented by AJCC/UICC 5th edition TNM stage
Cancer | Years | Method | Sex | Age | Stage | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|---|
Biliary | 2010-2014 | hybrid | Both | 15-99 | I | 1.00 years | 65.7% | 51.9% | 83.3% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | I | 5.00 years | 53.2% | 37.9% | 74.8% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | I | 10.00 years | 41.5% | 26.7% | 64.6% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | II | 1.00 years | 78.3% | 69.6% | 88.1% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | II | 5.00 years | 43.6% | 32.8% | 57.9% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | II | 10.00 years | 39.5% | 26.7% | 58.5% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | III | 1.00 years | 57.0% | 48.4% | 67.1% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | III | 5.00 years | 25.9% | 18.5% | 36.2% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | III | 10.00 years | 17.5% | 10.4% | 29.6% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | IV | 1.00 years | 28.1% | 24.0% | 33.0% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | IV | 5.00 years | 6.7% | 4.4% | 10.2% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | IV | 10.00 years | 2.8% | 1.1% | 7.2% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | unknown | 1.00 years | 25.1% | 20.4% | 31.0% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | unknown | 5.00 years | 8.2% | 5.2% | 12.8% |
Biliary | 2010-2014 | hybrid | Both | 15-99 | unknown | 10.00 years | 7.4% | 4.3% | 13.0% |